Akumin (TSE:AKU) and (BUX) (CNSX:BUX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.
Earnings & Valuation
This table compares Akumin and (BUX)'s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Akumin | C$246.08 million | 1.10 | $-25,263,475.00 | C($0.37) | -10.71 |
(BUX) | N/A | N/A | N/A | N/A | N/A |
(BUX) has lower revenue, but higher earnings than Akumin.
Profitability
This table compares Akumin and (BUX)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Akumin | N/A | N/A | N/A |
(BUX) | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Akumin and (BUX), as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Akumin | 0 | 1 | 1 | 0 | 2.50 |
(BUX) | 0 | 0 | 0 | 0 | N/A |
Akumin presently has a consensus target price of C$4.25, indicating a potential upside of 8.70%.
Summary
Akumin beats (BUX) on 2 of the 2 factors compared between the two stocks.